Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Leukemia

Free Subscription Articles published in Leukemia Retrieve available abstracts of 319 articles: HTML format Text format

Single Articles

March 2010
1. HOCKLEY SL , Morilla A, Else M, Dearden C, et al
   Higher expression levels of activation-induced cytidine deaminase distinguish hairy cell leukemia from hairy cell leukemia-variant and splenic marginal zone lymphoma.
   Leukemia. 2010.
   PubMed     Text format     Related articles   
   
   
   
2. DAVIDSSON J , Paulsson K, Lindgren D, Lilljebjorn H, et al
   Relapsed childhood high hyperdiploid acute lymphoblastic leukemia: presence of preleukemic ancestral clones and the secondary nature of microdeletions and RTK-RAS mutations.
   Leukemia. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
3. DENEBERG S , Grovdal M, Karimi M, Jansson M, et al
   Gene-specific and global methylation patterns predict outcome in patients with acute myeloid leukemia.
   Leukemia. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
4. GIANNOPOULOS K , Dmoszynska A, Kowal M, Rolinski J, et al
   Peptide vaccination elicits leukemia-associated antigen-specific cytotoxic CD8(+) T-cell responses in patients with chronic lymphocytic leukemia.
   Leukemia. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
5. YU H , Li Y, Gao C, Fabien L, et al
   Relevant mouse model for human monocytic leukemia through Cre/lox-controlled myeloid-specific deletion of PTEN.
   Leukemia. 2010.
   PubMed     Text format     Related articles   
   
   
   
6. CHEN J , Li Y, Doedens M, Wang P, et al
   Functional differences between myeloid leukemia-initiating and transient leukemia cells in Down's syndrome.
   Leukemia. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
7. VAISITTI T , Aydin S, Rossi D, Cottino F, et al
   CD38 increases CXCL12-mediated signals and homing of chronic lymphocytic leukemia cells.
   Leukemia. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
8. LANDMEIER S , Altvater B, Pscherer S, Meltzer J, et al
   Cytotoxic T cells transduced with chimeric anti-CD19 receptors prevent engraftment of primary lymphoblastic leukemia in vivo.
   Leukemia. 2010.
   PubMed     Text format     Related articles   
   
   
   
9. CHU S , McDonald T, Bhatia R
   Role of BCR-ABL-Y177-mediated p27kip1 phosphorylation and cytoplasmic localization in enhanced proliferation of chronic myeloid leukemia progenitors.
   Leukemia. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
10. MARTELLI AM , Papa V, Tazzari PL, Ricci F, et al
    Erucylphosphohomocholine, the first intravenously applicable alkylphosphocholine, is cytotoxic to acute myelogenous leukemia cells through JNK- and PP2A-dependent mechanisms.
    Leukemia. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
11. SCHMIEGELOW K , Forestier E, Hellebostad M, Heyman M, et al
    Long-term results of NOPHO ALL-92 and ALL-2000 studies of childhood acute lymphoblastic leukemia.
    Leukemia. 2010;24:670.
    PubMed     Text format     Related articles   
    
    
    February 2010
12. BOULTWOOD J , Perry J, Pellagatti A, Fernandez-Mercado M, et al
    Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia.
    Leukemia. 2010.
    PubMed     Text format     Related articles   
    
    
    
13. JUNG R , Jacobs U, Krumbholz M, Langer T, et al
    Bimodal distribution of genomic MLL breakpoints in infant acute lymphoblastic leukemia treatment.
    Leukemia. 2010.
    PubMed     Text format     Related articles   
    
    
    
14. BHAT UG , Gartel AL
    Nucleoside analog ARC targets Mcl-1 to induce apoptosis in leukemia cells.
    Leukemia. 2010.
    PubMed     Text format     Related articles   
    
    
    
15. ENGLER JR , Frede A, Saunders VA, Zannettino AC, et al
    Chronic Myeloid Leukemia CD34+ cells have reduced uptake of imatinib due to low OCT-1 Activity.
    Leukemia. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
16. SCHMIEGELOW K , Heyman M, Gustafsson G, Lausen B, et al
    The degree of myelosuppression during maintenance therapy of adolescents with B-lineage intermediate risk acute lymphoblastic leukemia predicts risk of relapse.
    Leukemia. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
17. TRACEY L , Streck CJ, Du Z, Williams RF, et al
    NF-kappaB activation mediates resistance to IFNbeta in MLL-rearranged acute lymphoblastic leukemia.
    Leukemia. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
18. SCHRAPPE M , Nachman J, Hunger S, Schmiegelow K, et al
    'Educational symposium on long-term results of large prospective clinical trials for childhood acute lymphoblastic leukemia (1985-2000)'.
    Leukemia. 2010;24:253-4.
    PubMed     Text format     Related articles   
    
    
    
19. ESCHERICH G , Horstmann MA, Zimmermann M, Janka-Schaub GE, et al
    Cooperative study group for childhood acute lymphoblastic leukaemia (COALL): long-term results of trials 82,85,89,92 and 97.
    Leukemia. 2010;24:298-308.
    PubMed     Text format     Related articles    Abstract available
    
    
    
20. KRISHNAN S , Wade R, Moorman AV, Mitchell C, et al
    Temporal changes in the incidence and pattern of central nervous system relapses in children with acute lymphoblastic leukaemia treated on four consecutive Medical Research Council trials, 1985-2001.
    Leukemia. 2010;24:450-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
21. LICCIULLI S , Cambiaghi V, Scafetta G, Gruszka AM, et al
    Pirin downregulation is a feature of AML and leads to impairment of terminal myeloid differentiation.
    Leukemia. 2010;24:429-37.
    PubMed     Text format     Related articles    Abstract available
    
    
    
22. MITCHELL C , Richards S, Harrison CJ, Eden T, et al
    Long-term follow-up of the United Kingdom medical research council protocols for childhood acute lymphoblastic leukaemia, 1980-2001.
    Leukemia. 2010;24:406-18.
    PubMed     Text format     Related articles    Abstract available
    
    
    
23. CARBUCCIA N , Trouplin V, Gelsi-Boyer V, Murati A, et al
    Mutual exclusion of ASXL1 and NPM1 mutations in a series of acute myeloid leukemias.
    Leukemia. 2010;24:469-73.
    PubMed     Text format     Related articles   
    
    
    
24. SCHACHTER-TOKARZ E , Kelaidi C, Cassinat B, Chomienne C, et al
    PML-RARalpha ligand-binding domain deletion mutations associated with reduced disease control and outcome after first relapse of APL.
    Leukemia. 2010;24:473-6.
    PubMed     Text format     Related articles   
    
    
    
25. RENNEVILLE A , Kaltenbach S, Clappier E, Collette S, et al
    Wilms tumor 1 (WT1) gene mutations in pediatric T-cell malignancies.
    Leukemia. 2010;24:476-80.
    PubMed     Text format     Related articles   
    
    
    
26. CHEVALLIER P , Prebet T, Pigneux A, Hunault M, et al
    Influence of NPM1 and FLT3-ITD status on outcome in relapsed/refractory AML patients receiving salvage therapy including gemtuzumab ozogamicin.
    Leukemia. 2010;24:467-9.
    PubMed     Text format     Related articles   
    
    
    January 2010
27. FEI F , Stoddart S, Muschen M, Kim YM, et al
    Development of resistance to dasatinib in Bcr/Abl-positive acute lymphoblastic leukemia.
    Leukemia. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
28. MANNARI D , Gascoyne D, Dunne J, Chaplin T, et al
    A novel exon in AML1-ETO negatively influences the clonogenic potential of the t(8;21) in acute myeloid leukemia.
    Leukemia. 2010.
    PubMed     Text format     Related articles   
    
    
    
29. LANCET JE , Gojo I, Burton M, Quinn M, et al
    Phase I study of the heat shock protein 90 inhibitor alvespimycin (KOS-1022, 17-DMAG) administered intravenously twice weekly to patients with acute myeloid leukemia.
    Leukemia. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
30. TARNANI M , D'Arena G, Efremov DG, Marietti S, et al
    The use of low-dose alemtuzumab in pretreated B-cell chronic lymphocytic leukemia.
    Leukemia. 2010.
    PubMed     Text format     Related articles   
    
    
    
31. PANTIC M , Schroettner P, Pfeifer D, Rawluk J, et al
    Biclonal origin prevails in concomitant chronic lymphocytic leukemia and multiple myeloma.
    Leukemia. 2010.
    PubMed     Text format     Related articles   
    
    
    
32. HACKANSON B , Abdelkarim M, Jansen JH, Lubbert M, et al
    NHR4 domain mutations of ETO are probably very infrequent in AML1-ETO positive myeloid leukemia cells.
    Leukemia. 2010.
    PubMed     Text format     Related articles   
    
    
    
33. AZOUZ A , Wu YL, Hillion J, Tarkanyi I, et al
    Epigenetic plasticity of hTERT gene promoter determines retinoid capacity to repress telomerase in maturation-resistant acute promyelocytic leukemia cells.
    Leukemia. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
34. LIU T , Jankovic D, Brault L, Ehret S, et al
    Functional characterization of high levels of meningioma 1 as collaborating oncogene in acute leukemia.
    Leukemia. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
35. LECLERC GJ , Mou C, Leclerc GM, Mian AM, et al
    Histone deacetylase inhibitors induce FPGS mRNA expression and intracellular accumulation of long-chain methotrexate polyglutamates in childhood acute lymphoblastic leukemia: implications for combination therapy.
    Leukemia. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
36. HERREROS B , Rodriguez-Pinilla SM, Pajares R, Martinez-Gonzalez MA, et al
    Proliferation centers in chronic lymphocytic leukemia: the niche where NF-kappaB activation takes place.
    Leukemia. 2010.
    PubMed     Text format     Related articles   
    
    
    
37. VAN DER REIJDEN BA , Massop M, Simons A, de Witte T, et al
    The NDE1 gene is disrupted by the inv(16) in 90% of cases with CBFB-MYH11-positive acute myeloid leukemia.
    Leukemia. 2010.
    PubMed     Text format     Related articles   
    
    
    
38. BURGER JA , Velev NS, Jabbour EJ, Wierda WG, et al
    Failure is not fatal: long-term remission in refractory acute myeloid leukemia (AML) after graft failure of cord blood stem cells.
    Leukemia. 2010.
    PubMed     Text format     Related articles   
    
    
    
39. YANG W , Trevino LR, Yang JJ, Scheet P, et al
    ARID5B SNP rs10821936 is associated with risk of childhood acute lymphoblastic leukemia in blacks and contributes to racial differences in leukemia incidence.
    Leukemia. 2010.
    PubMed     Text format     Related articles   
    
    
    December 2009
40. TSUCHIDA M , Ohara A, Manabe A, Kumagai M, et al
    Long-term results of Tokyo Children's Cancer Study Group trials for childhood acute lymphoblastic leukemia, 1984-1999.
    Leukemia. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
41. FOON KA , Hallek MJ
    Changing paradigms in the treatment of chronic lymphocytic leukemia.
    Leukemia. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
42. TSURUSAWA M , Shimomura Y, Asami K, Kikuta A, et al
    Long-term results of the Japanese Childhood Cancer and Leukemia Study Group studies 811, 841, 874 and 911 on childhood acute lymphoblastic leukemia.
    Leukemia. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
43. LIANG DC , Yang CP, Lin DT, Hung IJ, et al
    Long-term results of Taiwan Pediatric Oncology Group studies 1997 and 2002 for childhood acute lymphoblastic leukemia.
    Leukemia. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
44. SILVERMAN LB , Stevenson KE, O'Brien JE, Asselin BL, et al
    Long-term results of Dana-Farber Cancer Institute ALL Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1985-2000).
    Leukemia. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
45. CONTER V , Arico M, Basso G, Biondi A, et al
    Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) Studies 82, 87, 88, 91 and 95 for childhood acute lymphoblastic leukemia.
    Leukemia. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
46. STARY J , Jabali Y, Trka J, Hrusak O, et al
    Long-term results of treatment of childhood acute lymphoblastic leukemia in the Czech Republic.
    Leukemia. 2009.
    PubMed     Text format     Related articles   
    
    
    
47. STARK B , Nirel R, Avrahami G, Abramov A, et al
    Long-term results of the Israeli National Studies in childhood acute lymphoblastic leukemia: INS 84, 89 and 98.
    Leukemia. 2009.
    PubMed     Text format     Related articles   
    
    
    
48. BULLINGER L , Kronke J, Schon C, Radtke I, et al
    Identification of acquired copy number alterations and uniparental disomies in cytogenetically normal acute myeloid leukemia using high-resolution single-nucleotide polymorphism analysis.
    Leukemia. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
49. ABBAS S , Erpelinck-Verschueren CA, Goudswaard CS, Lowenberg B, et al
    Mutant Wilms' tumor 1 (WT1) mRNA with premature termination codons in acute myeloid leukemia (AML) is sensitive to nonsense-mediated RNA decay (NMD).
    Leukemia. 2009.
    PubMed     Text format     Related articles   
    
    
    
50. GAYNON PS , Angiolillo AL, Carroll WL, Nachman JB, et al
    Long-term results of the children's cancer group studies for childhood acute lymphoblastic leukemia 1983-2002: A Children's Oncology Group Report.
    Leukemia. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
51. KAMPS WA , van der Pal-de Bruin KM, Veerman AJ, Fiocco M, et al
    Long-term results of Dutch Childhood Oncology Group studies for children with acute lymphoblastic leukemia from 1984 to 2004.
    Leukemia. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
52. SALZER WL , Devidas M, Carroll WL, Winick N, et al
    Long-term results of the pediatric oncology group studies for childhood acute lymphoblastic leukemia 1984-2001: a report from the children's oncology group.
    Leukemia. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
53. MORICKE A , Zimmermann M, Reiter A, Henze G, et al
    Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000.
    Leukemia. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
54. SCHMIEGELOW K , Forestier E, Hellebostad M, Heyman M, et al
    Long-term results of NOPHO ALL-92 and ALL-2000 studies of childhood acute lymphoblastic leukemia.
    Leukemia. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
55. PUI CH , Pei D, Sandlund JT, Ribeiro RC, et al
    Long-term results of St Jude Total Therapy Studies 11, 12, 13A, 13B, and 14 for childhood acute lymphoblastic leukemia.
    Leukemia. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
56. TONINO SH , van Gelder M, Eldering E, van Oers MH, et al
    R-DHAP is effective in fludarabine-refractory chronic lymphocytic leukemia.
    Leukemia. 2009.
    PubMed     Text format     Related articles   
    
    
    
57. CASTRO JE , James DF, Sandoval-Sus JD, Jain S, et al
    Rituximab in combination with high-dose methylprednisolone for the treatment of chronic lymphocytic leukemia.
    Leukemia. 2009;23:2326.
    PubMed     Text format     Related articles   
    
    
    
58. RAFF T , Bruggemann M
    Leukemia: Methods and Protocols.
    Leukemia. 2009;23:2325.
    PubMed     Text format     Related articles   
    
    
    
59. PINKEL D
    'Allogeneic marrow transplantation in children with acute leukemia: a practice whose time has gone': twenty years later.
    Leukemia. 2009;23:2189-2196.
    PubMed     Text format     Related articles   
    
    
    November 2009
60. GERBY B , Armstrong F, de la Grange PB, Medyouf H, et al
    Optimized gene transfer into human primary leukemic T cell with NOD-SCID/leukemia-initiating cell activity.
    Leukemia. 2009.
    PubMed     Text format     Related articles   
    
    
    
61. PUISSANT A , Colosetti P, Robert G, Cassuto JP, et al
    Cathepsin B release after imatinib-mediated lysosomal membrane permeabilization triggers BCR-ABL cleavage and elimination of chronic myelogenous leukemia cells.
    Leukemia. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
62. ZUM BUSCHENFELDE CM , Wagner M, Lutzny G, Oelsner M, et al
    Recruitment of PKC-betaII to lipid rafts mediates apoptosis-resistance in chronic lymphocytic leukemia expressing ZAP-70.
    Leukemia. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
63. CHAPIRO E , Russell L, Lainey E, Kaltenbach S, et al
    Activating mutation in the TSLPR gene in B-cell precursor lymphoblastic leukemia.
    Leukemia. 2009.
    PubMed     Text format     Related articles   
    
    
    
64. KANG R , Tang D, Yu Y, Wang Z, et al
    WAVE1 regulates Bcl-2 localization and phosphorylation in leukemia cells.
    Leukemia. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
65. BIONDI A , Baruchel A, Hunger S, Masera G, et al
    The Eleventh International Childhood Acute Lymphoblastic Leukemia Workshop Report: Ponte di Legno, Italy, 6-7 May 2009.
    Leukemia. 2009.
    PubMed     Text format     Related articles   
    
    
    
66. RIX U , Remsing Rix LL, Terker AS, Fernbach NV, et al
    A comprehensive target selectivity survey of the BCR-ABL kinase inhibitor INNO-406 by kinase profiling and chemical proteomics in chronic myeloid leukemia cells.
    Leukemia. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    October 2009
67. SANCHEZ-AGUILERA A , Rattmann I, Drew DZ, Muller LU, et al
    Involvement of RhoH GTPase in the development of B-cell chronic lymphocytic leukemia.
    Leukemia. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
68. SECCHIERO P , di Iasio MG, Melloni E, Voltan R, et al
    The expression levels of the pro-apoptotic XAF-1 gene modulate the cytotoxic response to Nutlin-3 in B chronic lymphocytic leukemia.
    Leukemia. 2009.
    PubMed     Text format     Related articles   
    
    
    
69. JOTTA PY , Ganazza MA, Silva A, Viana MB, et al
    Negative prognostic impact of PTEN mutation in pediatric T-cell acute lymphoblastic leukemia.
    Leukemia. 2009.
    PubMed     Text format     Related articles   
    
    
    
70. JONGMANS MC , Kuiper RP, Carmichael CL, Wilkins EJ, et al
    Novel RUNX1 mutations in familial platelet disorder with enhanced risk for acute myeloid leukemia: clues for improved identification of the FPD/AML syndrome.
    Leukemia. 2009.
    PubMed     Text format     Related articles   
    
    
    
71. MAISO P , Colado E, Ocio EM, Garayoa M, et al
    The synergy of panobinostat plus doxorubicin in acute myeloid leukemia suggests a role for HDAC inhibitors in the control of DNA repair.
    Leukemia. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
72. SHUSTIK C , Turner AR, Desjardins P, Fernandez L, et al
    Oral fludarabine in untreated patients with B-cell chronic lymphocytic leukemia.
    Leukemia. 2009.
    PubMed     Text format     Related articles   
    
    
    
73. JABBOUR E , Hochhaus A, Cortes J, La Rosee P, et al
    Choosing the best treatment strategy for chronic myeloid leukemia patients resistant to imatinib: weighing the efficacy and safety of individual drugs with BCR-ABL mutations and patient history.
    Leukemia. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2009
74. MOLTENI CG , Te Kronnie G, Bicciato S, Villa T, et al
    PTPN11 mutations in childhood acute lymphoblastic leukemia occur as a secondary event associated with high hyperdiploidy.
    Leukemia. 2009.
    PubMed     Text format     Related articles   
    
    
    
75. MUSTJOKI S , Rohon P, Rapakko K, Jalkanen S, et al
    Low or undetectable numbers of Philadelphia chromosome-positive leukemic stem cells (Ph(+)CD34(+)CD38(neg)) in chronic myeloid leukemia patients in complete cytogenetic remission after tyrosine kinase inhibitor therapy.
    Leukemia. 2009.
    PubMed     Text format     Related articles   
    
    
    
76. IACOBUCCI I , Lonetti A, Messa F, Ferrari A, et al
    Different isoforms of the B-cell mutator activation-induced cytidine deaminase are aberrantly expressed in BCR-ABL1-positive acute lymphoblastic leukemia patients.
    Leukemia. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
77. LAPILLONNE H , Llopis L, Auvrignon A, Renneville A, et al
    Extensive mutational status of genes and clinical outcome in pediatric acute myeloid leukemia.
    Leukemia. 2009.
    PubMed     Text format     Related articles   
    
    
    
78. SPANER DE , Shi Y, White D, Shaha S, et al
    A phase I/II trial of TLR-7 agonist immunotherapy in chronic lymphocytic leukemia.
    Leukemia. 2009.
    PubMed     Text format     Related articles   
    
    
    
79. DARZENTAS N , Hadzidimitriou A, Murray F, Hatzi K, et al
    A different ontogenesis for chronic lymphocytic leukemia cases carrying stereotyped antigen receptors: molecular and computational evidence.
    Leukemia. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
80. LENGFELDER E , Haferlach C, Saussele S, Haferlach T, et al
    High dose ara-C in the treatment of newly diagnosed acute promyelocytic leukemia: long-term results of the German AMLCG.
    Leukemia. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
81. HIJIYA N , Gaynon P, Barry E, Silverman L, et al
    A multi-center phase I study of clofarabine, etoposide and cyclophosphamide in combination in pediatric patients with refractory or relapsed acute leukemia.
    Leukemia. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
82. GUNNARSSON R , Isaksson A, Mansouri M, Goransson H, et al
    Large but not small copy-number alterations correlate to high-risk genomic aberrations and survival in chronic lymphocytic leukemia: a high-resolution genomic screening of newly diagnosed patients.
    Leukemia. 2009.
    PubMed     Text format     Related articles   
    
    
    
83. VAN CASTEREN NJ , Pieters R, Dohle GR, van Baalen M, et al
    Cranial irradiation does not result in pituitary-gonadal axis dysfunction in very long-term male survivors of childhood acute lymphoblastic leukemia.
    Leukemia. 2009.
    PubMed     Text format     Related articles   
    
    
    
84. AYALA F , Dewar R, Kieran M, Kalluri R, et al
    Contribution of bone microenvironment to leukemogenesis and leukemia progression.
    Leukemia. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
85. KORVER W , Zhao X, Singh S, Pardoux C, et al
    Monoclonal antibodies against IREM-1: potential for targeted therapy of AML.
    Leukemia. 2009;23:1587-97.
    PubMed     Text format     Related articles    Abstract available
    
    
    
86. IKEZOE T , Yang J, Nishioka C, Takezaki Y, et al
    A novel treatment strategy targeting polo-like kinase 1 in hematological malignancies.
    Leukemia. 2009;23:1564-76.
    PubMed     Text format     Related articles    Abstract available
    
    
    
87. MIAN AA , Schull M, Zhao Z, Oancea C, et al
    The gatekeeper mutation T315I confers resistance against small molecules by increasing or restoring the ABL-kinase activity accompanied by aberrant transphosphorylation of endogenous BCR, even in loss-of-function mutants of BCR/ABL.
    Leukemia. 2009;23:1614-21.
    PubMed     Text format     Related articles    Abstract available
    
    
    
88. QIAN Z , Mao L, Fernald AA, Yu H, et al
    Enhanced expression of FHL2 leads to abnormal myelopoiesis in vivo.
    Leukemia. 2009;23:1650-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
89. WEBER G , Karbach J, Kuci S, Kreyenberg H, et al
    WT1 peptide-specific T cells generated from peripheral blood of healthy donors: possible implications for adoptive immunotherapy after allogeneic stem cell transplantation.
    Leukemia. 2009;23:1634-42.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2009
90. DAVIES A , Jordanides NE, Giannoudis A, Lucas CM, et al
    Nilotinib concentration in cell lines and primary CD34(+) chronic myeloid leukemia cells is not mediated by active uptake or efflux by major drug transporters.
    Leukemia. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
91. HASEGAWA H , Yamada Y, Iha H, Tsukasaki K, et al
    Activation of p53 by Nutlin-3a, an antagonist of MDM2, induces apoptosis and cellular senescence in adult T-cell leukemia cells.
    Leukemia. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
92. STAMATOPOULOS B , Meuleman N, De Bruyn C, Mineur P, et al
    Antileukemic activity of valproic acid in chronic lymphocytic leukemia B cells defined by microarray analysis.
    Leukemia. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
93. ONO R , Kumagai H, Nakajima H, Hishiya A, et al
    Mixed-lineage-leukemia (MLL) fusion protein collaborates with Ras to induce acute leukemia through aberrant Hox expression and Raf activation.
    Leukemia. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
94. CASTRO JE , James DF, Sandoval-Sus JD, Jain S, et al
    Rituximab in combination with high-dose methylprednisolone for the treatment of chronic lymphocytic leukemia.
    Leukemia. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
95. NISHIOKA C , Ikezoe T, Yang J, Yokoyama A, et al
    Multitargeted tyrosine kinase inhibitor stimulates expression of IL-6 and activates JAK2/STAT5 signaling in acute myelogenous leukemia cells.
    Leukemia. 2009.
    PubMed     Text format     Related articles   
    
    
    
96. EBERHART K , Renner K, Ritter I, Kastenberger M, et al
    Low doses of 2-deoxy-glucose sensitize acute lymphoblastic leukemia cells to glucocorticoid-induced apoptosis.
    Leukemia. 2009.
    PubMed     Text format     Related articles   
    
    
    
97. NISHIOKA C , Ikezoe T, Yang J, Yokoyama A, et al
    Sunitinib, an orally available receptor tyrosine kinase inhibitor, induces monocytic differentiation of acute myelogenous leukemia cells that is enhanced by 1,25-dihydroxyvitamin D(3).
    Leukemia. 2009.
    PubMed     Text format     Related articles   
    
    
    
98. DAHL S , Schmidt LS, Vestergaard T, Schuz J, et al
    Allergy and the risk of childhood leukemia: a meta-analysis.
    Leukemia. 2009.
    PubMed     Text format     Related articles   
    
    
    
99. BHAT R , Malinge S, Gamis AS, Sorrell AD, et al
    Mutational analysis of candidate tumor-associated genes in acute megakaryoblastic leukemia.
    Leukemia. 2009.
    PubMed     Text format     Related articles   
    
    
    
100. WILLASCH AM , Gruhn B, Coliva T, Kalinova M, et al
     Standardization of WT1 mRNA quantitation for minimal residual disease monitoring in childhood AML and implications of WT1 gene mutations: a European multicenter study.
     Leukemia. 2009;23:1472-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
101. NAUGHTON R , Quiney C, Turner SD, Cotter TG, et al
     Bcr-Abl-mediated redox regulation of the PI3K/AKT pathway.
     Leukemia. 2009;23:1432-40.
     PubMed     Text format     Related articles    Abstract available
     
     
     
102. PARDANANI A , Lasho T, Smith G, Burns CJ, et al
     CYT387, a selective JAK1/JAK2 inhibitor: in vitro assessment of kinase selectivity and preclinical studies using cell lines and primary cells from polycythemia vera patients.
     Leukemia. 2009;23:1441-5.
     PubMed     Text format     Related articles    Abstract available
     
     
     
103. MUSTJOKI S , Ekblom M, Arstila TP, Dybedal I, et al
     Clonal expansion of T/NK-cells during tyrosine kinase inhibitor dasatinib therapy.
     Leukemia. 2009;23:1398-405.
     PubMed     Text format     Related articles    Abstract available
     
     
     
104. MEYER C , Kowarz E, Hofmann J, Renneville A, et al
     New insights to the MLL recombinome of acute leukemias.
     Leukemia. 2009;23:1490-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
105. TEN CATE B , Bremer E, de Bruyn M, Bijma T, et al
     A novel AML-selective TRAIL fusion protein that is superior to Gemtuzumab Ozogamicin in terms of in vitro selectivity, activity and stability.
     Leukemia. 2009;23:1389-97.
     PubMed     Text format     Related articles    Abstract available
     
     
     July 2009
106. DEL GIUDICE I , Osuji N, Dexter T, Brito-Babapulle V, et al
     B-cell prolymphocytic leukemia and chronic lymphocytic leukemia have distinctive gene expression signatures.
     Leukemia. 2009.
     PubMed     Text format     Related articles   
     
     
     
107. HOCHHAUS A , Muller MC, Radich J, Branford S, et al
     Dasatinib-associated major molecular responses in patients with chronic myeloid leukemia in chronic phase following imatinib failure: response dynamics and predictive value.
     Leukemia. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
108. MASON KD , Khaw SL, Rayeroux KC, Chew E, et al
     The BH3 mimetic compound, ABT-737, synergizes with a range of cytotoxic chemotherapy agents in chronic lymphocytic leukemia.
     Leukemia. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
109. FARFSING A , Engel F, Seiffert M, Hartmann E, et al
     Gene knockdown studies revealed CCDC50 as a candidate gene in mantle cell lymphoma and chronic lymphocytic leukemia.
     Leukemia. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
110. OSTERBORG A , Foa R, Bezares RF, Dearden C, et al
     Management guidelines for the use of alemtuzumab in chronic lymphocytic leukemia.
     Leukemia. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
111. SANCHEZ PV , Perry RL, Sarry JE, Perl AE, et al
     A robust xenotransplantation model for acute myeloid leukemia.
     Leukemia. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
112. SCHMIDT SM , Konig T, Bringmann A, Held S, et al
     Characterization of BAX inhibitor-1 as a novel leukemia-associated antigen.
     Leukemia. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
113. FAMILIADES J , Bousquet M, Lafage-Pochitaloff M, Bene MC, et al
     PAX5 mutations occur frequently in adult B-cell progenitor acute lymphoblastic leukemia and PAX5 haploinsufficiency is associated with BCR-ABL1 and TCF3-PBX1 fusion genes: a GRAALL study.
     Leukemia. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
114. FERRANDO AA
     Genomic technologies in leukemia and lymphoma: a review series.
     Leukemia. 2009;23:1207.
     PubMed     Text format     Related articles   
     
     
     
115. KILLMANN N
     Introduction to the genomics spotlight.
     Leukemia. 2009;23:1208.
     PubMed     Text format     Related articles   
     
     
     
116. PICCALUGA PP , Sabattini E, Bacci F, Agostinelli C, et al
     Cytoplasmic mutated nucleophosmin (NPM1) in blast crisis of chronic myeloid leukaemia.
     Leukemia. 2009;23:1370-1.
     PubMed     Text format     Related articles   
     
     
     
117. RIPPERGER T , Steinemann D, Gohring G, Finke J, et al
     A novel pedigree with heterozygous germline RUNX1 mutation causing familial MDS-related AML: can these families serve as a multistep model for leukemic transformation?
     Leukemia. 2009;23:1364-6.
     PubMed     Text format     Related articles   
     
     
     
118. MOUS R , Jaspers A, Luijks DM, Mellink CH, et al
     Detection of p53 dysfunction in chronic lymphocytic leukaemia cells through multiplex quantification of p53 target gene induction.
     Leukemia. 2009;23:1352-5.
     PubMed     Text format     Related articles   
     
     
     
119. CUI JW , Vecchiarelli-Federico LM, Li YJ, Wang GJ, et al
     Continuous Fli-1 expression plays an essential role in the proliferation and survival of F-MuLV-induced erythroleukemia and human erythroleukemia.
     Leukemia. 2009;23:1311-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     June 2009
120. ZEBISCH A , Haller M, Hiden K, Goebel T, et al
     Loss of RAF kinase inhibitor protein is a somatic event in the pathogenesis of therapy-related acute myeloid leukemias with C-RAF germline mutations.
     Leukemia. 2009;23:1049-53.
     PubMed     Text format     Related articles    Abstract available
     
     
     
121. MIRSHAHI P , Rafii A, Vincent L, Berthaut A, et al
     Vasculogenic mimicry of acute leukemic bone marrow stromal cells.
     Leukemia. 2009;23:1039-48.
     PubMed     Text format     Related articles    Abstract available
     
     
     
122. FIANCETTE R , Vincent C, Donnard M, Bordessoule D, et al
     Genes encoding multiple forms of phospholipase A(2) are expressed in immature forms of human leukemic blasts.
     Leukemia. 2009;23:1196-9.
     PubMed     Text format     Related articles   
     
     
     
123. DRUMMOND MW , Heaney N, Kaeda J, Nicolini FE, et al
     A pilot study of continuous imatinib vs pulsed imatinib with or without G-CSF in CML patients who have achieved a complete cytogenetic response.
     Leukemia. 2009;23:1199-201.
     PubMed     Text format     Related articles   
     
     
     
124. HIWASE DK , White DL, Saunders VA, Kumar S, et al
     Short-term intense Bcr-Abl kinase inhibition with nilotinib is adequate to trigger cell death in BCR-ABL(+) cells.
     Leukemia. 2009;23:1205-6.
     PubMed     Text format     Related articles   
     
     
     
125. REA D , Etienne G, Corm S, Cony-Makhoul P, et al
     Imatinib dose escalation for chronic phase-chronic myelogenous leukaemia patients in primary suboptimal response to imatinib 400 mg daily standard therapy.
     Leukemia. 2009;23:1193-6.
     PubMed     Text format     Related articles   
     
     
     
126. BALLABIO E , Cantarella CD, Federico C, Di Mare P, et al
     Ectopic expression of the HLXB9 gene is associated with an altered nuclear position in t(7;12) leukaemias.
     Leukemia. 2009;23:1179-82.
     PubMed     Text format     Related articles   
     
     
     
127. BOYD EM , Bench AJ, Vaghela KJ, Campbell GN, et al
     Therapy-related acute myeloid leukaemia with t(8;16)(p11;p13);MOZ-CBP and polymorphisms in detoxifying and DNA repair genes.
     Leukemia. 2009;23:1164-7.
     PubMed     Text format     Related articles   
     
     
     
128. MRAZ M , Malinova K, Kotaskova J, Pavlova S, et al
     miR-34a, miR-29c and miR-17-5p are downregulated in CLL patients with TP53 abnormalities.
     Leukemia. 2009;23:1159-63.
     PubMed     Text format     Related articles   
     
     
     
129. GALLAY N , Dos Santos C, Cuzin L, Bousquet M, et al
     The level of AKT phosphorylation on threonine 308 but not on serine 473 is associated with high-risk cytogenetics and predicts poor overall survival in acute myeloid leukaemia.
     Leukemia. 2009;23:1029-38.
     PubMed     Text format     Related articles    Abstract available
     
     
     
130. REA D , Raffoux E, Cayuela JM, Maarek O, et al
     Sustained major molecular response in the absence of any antileukaemic therapy after dasatinib treatment and autologous peripheral blood stem cell transplantation in a patient with imatinib-resistant myeloblastic-phase chronic myeloid leukaemia.
     Leukemia. 2009;23:1158-9.
     PubMed     Text format     Related articles   
     
     
     May 2009
131. CHENG Y , Wang Y, Wang H, Chen Z, et al
     Cytogenetic profile of de novo acute myeloid leukemia: a study based on 1432 patients in a single institution of China.
     Leukemia. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
132. GILES FJ , O'Dwyer M, Swords R
     Class effects of tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia.
     Leukemia. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
133. LEE JC , Yang S, Zou Y, Joseph L, et al
     Erythroid/B-cell biphenotypic acute leukemia first case report.
     Leukemia. 2009.
     PubMed     Text format     Related articles   
     
     
     
134. JIAO B , Wu CF, Liang Y, Chen HM, et al
     AML1-ETO9a is correlated with C-KIT overexpression/mutations and indicates poor disease outcome in t(8;21) acute myeloid leukemia-M2.
     Leukemia. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
135. CHO BS , Lee S, Kim YJ, Chung NG, et al
     Reduced-intensity conditioning allogeneic stem cell transplantation is a potential therapeutic approach for adults with high-risk acute lymphoblastic leukemia in remission: results of a prospective phase 2 study.
     Leukemia. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
136. GIANNOPOULOS K , Dmoszynska A, Kowal M, Wasik-Szczepanek E, et al
     Thalidomide exerts distinct molecular antileukemic effects and combined thalidomide/fludarabine therapy is clinically effective in high-risk chronic lymphocytic leukemia.
     Leukemia. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
137. VISANI G , Piccaluga P, Malagola M, Isidori A, et al
     Efficacy of dasatinib in conjunction with alpha-interferon for the treatment of imatinib-resistant and dasatinib-resistant Ph+ acute lymphoblastic leukemia.
     Leukemia. 2009.
     PubMed     Text format     Related articles   
     
     
     
138. HUSSEIN K , Bock O, Theophile K, Schulz-Bischof K, et al
     MPLW515L mutation in acute megakaryoblastic leukaemia.
     Leukemia. 2009;23:852-5.
     PubMed     Text format     Related articles    Abstract available
     
     
     
139. HAFERLACH T , Kohlmann A, Klein HU, Ruckert C, et al
     AML with translocation t(8;16)(p11;p13) demonstrates unique cytomorphological, cytogenetic, molecular and prognostic features.
     Leukemia. 2009;23:934-43.
     PubMed     Text format     Related articles    Abstract available
     
     
     
140. BRUNS I , Czibere A, Fischer JC, Roels F, et al
     The hematopoietic stem cell in chronic phase CML is characterized by a transcriptional profile resembling normal myeloid progenitor cells and reflecting loss of quiescence.
     Leukemia. 2009;23:892-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
141. HU Z , Li XM, Jorgensen ML, Slayton WB, et al
     MLL/AF-4 leukemic cells recruit new blood vessels but do not incorporate into capillaries in culture or in a NOD/SCID xenograft model.
     Leukemia. 2009;23:990-3.
     PubMed     Text format     Related articles   
     
     
     
142. ZALIOVA M , Fronkova E, Krejcikova K, Muzikova K, et al
     Quantification of fusion transcript reveals a subgroup with distinct biological properties and predicts relapse in BCR/ABL-positive ALL: implications for residual disease monitoring.
     Leukemia. 2009;23:944-51.
     PubMed     Text format     Related articles    Abstract available
     
     
     
143. ALLAN EK , Hamilton A, Hatziieremia S, Zhou P, et al
     Nuclear entrapment of BCR-ABL by combining imatinib mesylate with leptomycin B does not eliminate CD34+ chronic myeloid leukaemia cells.
     Leukemia. 2009;23:1006-8.
     PubMed     Text format     Related articles   
     
     
     
144. SUZUKI S , Nagel S, Schneider B, Chen S, et al
     A second NOTCH1 chromosome rearrangement: t(9;14)(q34.3;q11.2) in T-cell neoplasia.
     Leukemia. 2009;23:1003-6.
     PubMed     Text format     Related articles   
     
     
     
145. TAYLOR GM , Hussain A, Verhage V, Thompson PD, et al
     Strong association of the HLA-DP6 supertype with childhood leukaemia is due to a single allele, DPB1*0601.
     Leukemia. 2009;23:863-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
146. HOVES S , Aigner M, Pfeiffer C, Laumer M, et al
     In situ analysis of the antigen-processing machinery in acute myeloid leukaemic blasts by tissue microarray.
     Leukemia. 2009;23:877-85.
     PubMed     Text format     Related articles    Abstract available
     
     
     
147. VANDYKE K , Dewar AL, Farrugia AN, Fitter S, et al
     Therapeutic concentrations of dasatinib inhibit in vitro osteoclastogenesis.
     Leukemia. 2009;23:994-7.
     PubMed     Text format     Related articles   
     
     
     
148. BRUENNERT D , Czibere A, Bruns I, Kronenwett R, et al
     Early in vivo changes of the transcriptome in Philadelphia chromosome-positive CD34+ cells from patients with chronic myelogenous leukaemia following imatinib therapy.
     Leukemia. 2009;23:983-5.
     PubMed     Text format     Related articles   
     
     
     
149. KARAS-KUZELICKI N , Jazbec J, Milek M, Mlinaric-Rascan I, et al
     Heterozygosity at the TPMT gene locus, augmented by mutated MTHFR gene, predisposes to 6-MP related toxicities in childhood ALL patients.
     Leukemia. 2009;23:971-4.
     PubMed     Text format     Related articles   
     
     
     April 2009
150. CORTES JE , Egorin MJ, Guilhot F, Molimard M, et al
     Pharmacokinetic/pharmacodynamic correlation and blood-level testing in imatinib therapy for chronic myeloid leukemia.
     Leukemia. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
151. RAMBAL AA , Panaguiton ZL, Kramer L, Grant S, et al
     MEK inhibitors potentiate dexamethasone lethality in acute lymphoblastic leukemia cells through the pro-apoptotic molecule BIM.
     Leukemia. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
152. WEERKAMP F , Dekking E, Ng YY, van der Velden VH, et al
     Flow cytometric immunobead assay for the detection of BCR-ABL fusion proteins in leukemia patients.
     Leukemia. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
153. VALENCIA A , Roman-Gomez J, Cervera J, Such E, et al
     Wnt signaling pathway is epigenetically regulated by methylation of Wnt antagonists in acute myeloid leukemia.
     Leukemia. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
154. KERN W , Haferlach C, Bacher U, Haferlach T, et al
     Flow cytometric identification of acute myeloid leukemia with limited differentiation and NPM1 type A mutation: a new biologically defined entity.
     Leukemia. 2009.
     PubMed     Text format     Related articles   
     
     
     
155. KREYENBERG H , Eckert C, Yarkin Y, Reising M, et al
     Immunoglobulin and T-cell receptor gene rearrangements as PCR-based targets are stable markers for monitoring minimal residual disease in acute lymphoblastic leukemia after stem cell transplantation.
     Leukemia. 2009.
     PubMed     Text format     Related articles   
     
     
     
156. REAL PJ , Ferrando AA
     NOTCH inhibition and glucocorticoid therapy in T-cell acute lymphoblastic leukemia.
     Leukemia. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
157. KOBAYASHI S , Kimura F, Ikeda T, Osawa Y, et al
     BCR-ABL promotes neutrophil differentiation in the chronic phase of chronic myeloid leukemia by downregulating c-Jun expression.
     Leukemia. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
158. GAMAS P , Marchetti S, Puissant A, Grosso S, et al
     Inhibition of imatinib-mediated apoptosis by the caspase-cleaved form of the tyrosine kinase Lyn in chronic myelogenous leukemia cells.
     Leukemia. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
159. ROSSI D , Lobetti Bodoni C, Genuardi E, Monitillo L, et al
     Telomere length is an independent predictor of survival, treatment requirement and Richter's syndrome transformation in chronic lymphocytic leukemia.
     Leukemia. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
160. TYNER JW , Rutenberg-Schoenberg ML, Erickson H, Willis SG, et al
     Functional characterization of an activating TEK mutation in acute myeloid leukemia: a cellular context-dependent activating mutation.
     Leukemia. 2009.
     PubMed     Text format     Related articles   
     
     
     
161. LARSON GEDMAN A , Chen Q, Kugel Desmoulin S, Ge Y, et al
     The impact of NOTCH1, FBW7 and PTEN mutations on prognosis and downstream signaling in pediatric T-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group.
     Leukemia. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
162. ASHTON LJ , Gifford AJ, Kwan E, Lingwood A, et al
     Reduced folate carrier and methylenetetrahydrofolate reductase gene polymorphisms: associations with clinical outcome in childhood acute lymphoblastic leukemia.
     Leukemia. 2009.
     PubMed     Text format     Related articles   
     
     
     
163. PERUGINI M , Kok CH, Brown AL, Wilkinson CR, et al
     Repression of Gadd45alpha by activated FLT3 and GM-CSF receptor mutants contributes to growth, survival and blocked differentiation.
     Leukemia. 2009;23:729-38.
     PubMed     Text format     Related articles    Abstract available
     
     
     
164. BASARA N , Schulze A, Wedding U, Mohren M, et al
     Early related or unrelated haematopoietic cell transplantation results in higher overall survival and leukaemia-free survival compared with conventional chemotherapy in high-risk acute myeloid leukaemia patients in first complete remission.
     Leukemia. 2009;23:635-40.
     PubMed     Text format     Related articles    Abstract available
     
     
     
165. WAKEFORD R , Kendall GM, Little MP
     The proportion of childhood leukaemia incidence in Great Britain that may be caused by natural background ionizing radiation.
     Leukemia. 2009;23:770-6.
     PubMed     Text format     Related articles    Abstract available
     
     
     
166. POGGI A , Catellani S, Garuti A, Pierri I, et al
     Effective in vivo induction of NKG2D ligands in acute myeloid leukaemias by all-trans-retinoic acid or sodium valproate.
     Leukemia. 2009;23:641-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
167. MINELLI A , Maserati E, Nicolis E, Zecca M, et al
     The isochromosome i(7)(q10) carrying c.258+2t>c mutation of the SBDS gene does not promote development of myeloid malignancies in patients with Shwachman syndrome.
     Leukemia. 2009;23:708-11.
     PubMed     Text format     Related articles    Abstract available
     
     
     
168. ROSS DM , Branford S, Melo JV, Hughes TP, et al
     Reply to 'What do we mean by sensitivity when we talk about detecting minimal residual disease?' by Steinbach and Debatin.
     Leukemia. 2009;23:819-20.
     PubMed     Text format     Related articles   
     
     
     
169. DE HAAS V , Dee R, Cheroutre G, van den Berg H, et al
     Gene expression profile of slowly responding subclones might represent different profiles already at diagnosis and might be used for prediction of outcome.
     Leukemia. 2009;23:816-9.
     PubMed     Text format     Related articles   
     
     
     
170. CHEVALLIER P , Robillard N, Houille G, Ayari S, et al
     Simultaneous study of five candidate target antigens (CD20, CD22, CD33, CD52, HER2) for antibody-based immunotherapy in B-ALL: a monocentric study of 44 cases.
     Leukemia. 2009;23:806-7.
     PubMed     Text format     Related articles   
     
     
     March 2009
171. CHEN Y , Hu Y, Michaels S, Segal D, et al
     Inhibitory effects of omacetaxine on leukemic stem cells and BCR-ABL-induced chronic myeloid leukemia and acute lymphoblastic leukemia in mice.
     Leukemia. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
172. NEFF T , Armstrong SA
     Chromatin maps, histone modifications and leukemia.
     Leukemia. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
173. WOJISKI S , Guibal FC, Kindler T, Lee BH, et al
     PML-RARalpha initiates leukemia by conferring properties of self-renewal to committed promyelocytic progenitors.
     Leukemia. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
174. YANEZ L , Bermudez A, Richard C, Bureo E, et al
     Successful induction therapy with decitabine in refractory childhood acute lymphoblastic leukemia.
     Leukemia. 2009.
     PubMed     Text format     Related articles   
     
     
     
175. PUT N , Meeus P, Chatelain B, Rack K, et al
     Translocation t(14;18) is not associated with inferior outcome in chronic lymphocytic leukemia.
     Leukemia. 2009.
     PubMed     Text format     Related articles   
     
     
     
176. JEHA S , Pei D, Raimondi SC, Onciu M, et al
     Increased risk for CNS relapse in pre-B cell leukemia with the t(1;19)/TCF3-PBX1.
     Leukemia. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
177. HOCHHAUS A , O'Brien SG, Guilhot F, Druker BJ, et al
     Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia.
     Leukemia. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
178. ZHANG QL , Wang L, Zhang YW, Jiang XX, et al
     The proteasome inhibitor bortezomib interacts synergistically with the histone deacetylase inhibitor suberoylanilide hydroxamic acid to induce T-leukemia/lymphoma cells apoptosis.
     Leukemia. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
179. KUO MC , Liang DC, Huang CF, Shih YS, et al
     RUNX1 mutations are frequent in chronic myelomonocytic leukemia and mutations at the C-terminal region might predict acute myeloid leukemia transformation.
     Leukemia. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
180. KOTSIANIDIS I , Bouchliou I, Nakou E, Spanoudakis E, et al
     Kinetics, function and bone marrow trafficking of CD4+CD25+FOXP3+ regulatory T cells in myelodysplastic syndromes (MDS).
     Leukemia. 2009;23:510-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
181. BOLLI N , De Marco MF, Martelli MP, Bigerna B, et al
     A dose-dependent tug of war involving the NPM1 leukaemic mutant, nucleophosmin, and ARF.
     Leukemia. 2009;23:501-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
182. STRUSKI S , Gervais C, Helias C, Herbrecht R, et al
     Stimulation of B-cell lymphoproliferations with CpG-oligonucleotide DSP30 plus IL-2 is more effective than with TPA to detect clonal abnormalities.
     Leukemia. 2009;23:617-9.
     PubMed     Text format     Related articles   
     
     
     
183. CARLSSON G , Boxhammer S, Garwicz D, Henter JI, et al
     Survivin expression in the bone marrow of patients with severe congenital neutropenia.
     Leukemia. 2009;23:622-5.
     PubMed     Text format     Related articles   
     
     
     
184. DIJKSTRA MK , van Lom K, Tielemans D, Elstrodt F, et al
     17p13/TP53 deletion in B-CLL patients is associated with microRNA-34a downregulation.
     Leukemia. 2009;23:625-7.
     PubMed     Text format     Related articles   
     
     
     
185. LAWRIE CH , Shilling R, Troussard X, Cattan H, et al
     Expression profiling of persistent polyclonal B-cell lymphocytosis suggests constitutive expression of the AP-1 transcription complex and downregulation of Fas-apoptotic and TGFbeta signalling pathways.
     Leukemia. 2009;23:581-3.
     PubMed     Text format     Related articles   
     
     
     
186. BERNARD F , Gelsi-Boyer V, Murati A, Giraudier S, et al
     Alterations of NFIA in chronic malignant myeloid diseases.
     Leukemia. 2009;23:583-5.
     PubMed     Text format     Related articles   
     
     
     February 2009
187. MULLIGHAN CG , Downing JR
     Genome-wide profiling of genetic alterations in acute lymphoblastic leukemia: recent insights and future directions.
     Leukemia. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
188. RUBNITZ JE , Crews KR, Pounds S, Yang S, et al
     Combination of cladribine and cytarabine is effective for childhood acute myeloid leukemia: results of the St Jude AML97 trial.
     Leukemia. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
189. CHOU WC , Chen CY, Hou HA, Lin LI, et al
     Acute myeloid leukemia bearing t(7;11)(p15;p15) is a distinct cytogenetic entity with poor outcome and a distinct mutation profile: comparative analysis of 493 adult patients.
     Leukemia. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
190. WOYACH JA , Lin TS, Lucas MS, Heerema N, et al
     A phase I/II study of rituximab and etanercept in patients with chronic lymphocytic leukemia and small lymphocytic lymphoma.
     Leukemia. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
191. ROHRS S , Romani J, Zaborski M, Drexler HG, et al
     Hypermethylation of Death-Associated Protein Kinase 1 differentiates natural killer cell lines from cell lines derived from T-acute lymphoblastic leukemia.
     Leukemia. 2009.
     PubMed     Text format     Related articles   
     
     
     
192. VAN DER VELDEN VH , Corral L, Valsecchi MG, Jansen MW, et al
     Prognostic significance of minimal residual disease in infants with acute lymphoblastic leukemia treated within the Interfant-99 protocol.
     Leukemia. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
193. LIERMAN E , Michaux L, Beullens E, Pierre P, et al
     FIP1L1-PDGFRalpha D842V, a novel panresistant mutant, emerging after treatment of FIP1L1-PDGFRalpha T674I eosinophilic leukemia with single agent sorafenib.
     Leukemia. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
194. BUHL AM , Novotny GW, Josefsson P, Nielsen JE, et al
     The CLLU1 expression level is a stable and inherent feature of the chronic lymphocytic leukemia clone.
     Leukemia. 2009.
     PubMed     Text format     Related articles   
     
     
     
195. FURUHATA A , Murakami M, Ito H, Gao S, et al
     GATA-1 and GATA-2 binding to 3' enhancer of WT1 gene is essential for its transcription in acute leukemia and solid tumor cell lines.
     Leukemia. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
196. PRUCKER C , Attarbaschi A, Peters C, Dworzak MN, et al
     Induction death and treatment-related mortality in first remission of children with acute lymphoblastic leukemia: a population-based analysis of the Austrian Berlin-Frankfurt-Munster study group.
     Leukemia. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
197. FLOTHO C , Claus R, Batz C, Schneider M, et al
     The DNA methyltransferase inhibitors azacitidine, decitabine and zebularine exert differential effects on cancer gene expression in acute myeloid leukemia cells.
     Leukemia. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
198. LUO Y , Lai XY, Tan YM, Shi JM, et al
     Reduced-intensity allogeneic transplantation combined with imatinib mesylate for chronic myeloid leukemia in first chronic phase.
     Leukemia. 2009.
     PubMed     Text format     Related articles   
     
     
     
199. SANDLUND JT , Pui CH, Zhou Y, Behm FG, et al
     Effective treatment of advanced-stage childhood lymphoblastic lymphoma without prophylactic cranial irradiation: results of St Jude NHL13 study.
     Leukemia. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
200. LACOMBE F , Arnoulet C, Maynadie M, Lippert E, et al
     Early clearance of peripheral blasts measured by flow cytometry during the first week of AML induction therapy as a new independent prognostic factor: a GOELAMS study.
     Leukemia. 2009;23:350-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
201. HAYDEN RE , Pratt G, Davies NJ, Khanim FL, et al
     Treatment of primary CLL cells with bezafibrate and medroxyprogesterone acetate induces apoptosis and represses the pro-proliferative signal of CD40-ligand, in part through increased 15dDelta12,14,PGJ2.
     Leukemia. 2009;23:292-304.
     PubMed     Text format     Related articles    Abstract available
     
     
     
202. MARINELLI A , Bossi D, Pelicci PG, Minucci S, et al
     Redundant function of retinoic acid receptor isoforms in leukemogenesis unravels a prominent function of genome topology and architecture in the selection of mutagenic events in cancer.
     Leukemia. 2009;23:417-9.
     PubMed     Text format     Related articles   
     
     
     
203. LAMBA JK , Pounds S, Cao X, Downing JR, et al
     Coding polymorphisms in CD33 and response to gemtuzumab ozogamicin in pediatric patients with AML: a pilot study.
     Leukemia. 2009;23:402-4.
     PubMed     Text format     Related articles   
     
     
     January 2009
204. GUNN SR , Hibbard MK, Ismail SH, Lowery-Nordberg M, et al
     Atypical 11q deletions identified by array CGH may be missed by FISH panels for prognostic markers in chronic lymphocytic leukemia.
     Leukemia. 2009.
     PubMed     Text format     Related articles   
     
     
     
205. THOENE S , Rawat VP, Heilmeier B, Hoster E, et al
     The homeobox gene CDX2 is aberrantly expressed and associated with an inferior prognosis in patients with acute lymphoblastic leukemia.
     Leukemia. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
206. KELO E , Noronkoski T, Mononen I
     Depletion of L-asparagine supply and apoptosis of leukemia cells induced by human glycosylasparaginase.
     Leukemia. 2009.
     PubMed     Text format     Related articles   
     
     
     
207. BELLOC F , Airiau K, Jeanneteau M, Garcia M, et al
     The stem cell factor-c-KIT pathway must be inhibited to enable apoptosis induced by BCR-ABL inhibitors in chronic myelogenous leukemia cells.
     Leukemia. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
208. PALOMERO T , Ferrando AA
     Genomic tools for dissecting oncogenic transcriptional networks in human leukemia.
     Leukemia. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
209. KOSTARELI E , Hadzidimitriou A, Stavroyianni N, Darzentas N, et al
     Molecular evidence for EBV and CMV persistence in a subset of patients with chronic lymphocytic leukemia expressing stereotyped IGHV4-34 B-cell receptors.
     Leukemia. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
210. CSINADY E , van der Velden VH, Joas R, Fischer S, et al
     Chromosome 14 copy number-dependent IGH gene rearrangement patterns in high hyperdiploid childhood B-cell precursor ALL: implications for leukemia biology and minimal residual disease analysis.
     Leukemia. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
211. RAINER J , Ploner C, Jesacher S, Ploner A, et al
     Glucocorticoid-regulated microRNAs and mirtrons in acute lymphoblastic leukemia.
     Leukemia. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
212. YENDAMURI S , Calin GA
     The role of microRNA in human leukemia: a review.
     Leukemia. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
213. SEFAH K , Tang ZW, Shangguan DH, Chen H, et al
     Molecular recognition of acute myeloid leukemia using aptamers.
     Leukemia. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
214. WILLEMZE R , Rodrigues CA, Labopin M, Sanz G, et al
     KIR-ligand incompatibility in the graft-versus-host direction improves outcomes after umbilical cord blood transplantation for acute leukemia.
     Leukemia. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
215. DE MARCHIS ML , Ballarino M, Salvatori B, Puzzolo MC, et al
     A new molecular network comprising PU.1, interferon regulatory factor proteins and miR-342 stimulates ATRA-mediated granulocytic differentiation of acute promyelocytic leukemia cells.
     Leukemia. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
216. SEIFERT H , Mohr B, Thiede C, Oelschlagel U, et al
     The prognostic impact of 17p (p53) deletion in 2272 adults with acute myeloid leukemia.
     Leukemia. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
217. TANG L , Bergevoet SM, Franssen LE, de Witte T, et al
     Exclusion of ABCB8 and ABCB10 as cancer candidate genes in acute myeloid leukemia.
     Leukemia. 2009.
     PubMed     Text format     Related articles   
     
     
     
218. LIU X , Zhang Q, Zhang DE, Zhou C, et al
     Overexpression of an isoform of AML1 in acute leukemia and its potential role in leukemogenesis.
     Leukemia. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
219. GRUBER G , Carlet M, Turtscher E, Meister B, et al
     Levels of glucocorticoid receptor and its ligand determine sensitivity and kinetics of glucocorticoid-induced leukemia apoptosis.
     Leukemia. 2009.
     PubMed     Text format     Related articles   
     
     
     
220. BEST OG , Gardiner AC, Davis ZA, Tracy I, et al
     A subset of Binet stage A CLL patients with TP53 abnormalities and mutated IGHV genes have stable disease.
     Leukemia. 2009;23:212-4.
     PubMed     Text format     Related articles   
     
     
     
221. LONNERHOLM G , Nordgren A, Frost BM, Jonsson OG, et al
     Dic(9;20)(p13;q11) in childhood acute lymphoblastic leukaemia is related to low cellular resistance to asparaginase, cytarabine and corticosteroids.
     Leukemia. 2009;23:209-12.
     PubMed     Text format     Related articles   
     
     
     
222. CAZZANIGA G , Lo Nigro L, Cifola I, Milone G, et al
     Simultaneous occurrence of acute myeloid leukaemia with mutated nucleophosmin (NPM1) in the same family.
     Leukemia. 2009;23:199-203.
     PubMed     Text format     Related articles   
     
     
     
223. SORIA NM , Tussiwand R, Ziegler P, Manz MG, et al
     Transient depletion of RUNX1/RUNX1T1 by RNA interference delays tumour formation in vivo.
     Leukemia. 2009;23:188-90.
     PubMed     Text format     Related articles   
     
     
     December 2008
224. BAOU M , Jewell A, Muthurania A, Wickremasinghe RG, et al
     Involvement of Tis11b, an AU-rich binding protein, in induction of apoptosis by rituximab in B cell chronic lymphocytic leukemia cells.
     Leukemia. 2008.
     PubMed     Text format     Related articles   
     
     
     
225. PEREZ-GARCIA A , Brunet S, Berlanga JJ, Tormo M, et al
     CTLA-4 genotype and relapse incidence in patients with acute myeloid leukemia in first complete remission after induction chemotherapy.
     Leukemia. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
226. BRANDWEIN JM , Leber BF, Howson-Jan K, Schimmer AD, et al
     A phase I study of tipifarnib combined with conventional induction and consolidation therapy for previously untreated patients with acute myeloid leukemia aged 60 years and over.
     Leukemia. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
227. GIANNOPOULOS K , Mertens D, Buhler A, Barth TF, et al
     The candidate immunotherapeutical target, the receptor for hyaluronic acid-mediated motility, is associated with proliferation and shows prognostic value in B-cell chronic lymphocytic leukemia.
     Leukemia. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
228. GOBESSI S , Laurenti L, Longo PG, Carsetti L, et al
     Inhibition of constitutive and BCR-induced Syk activation downregulates Mcl-1 and induces apoptosis in chronic lymphocytic leukemia B cells.
     Leukemia. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
229. TSUMURA H , Akimoto M, Kiyota H, Ishii Y, et al
     Gene expression profiles in differentiating leukemia cells induced by methyl jasmonate are similar to those of cytokinins and methyl jasmonate analogs induce the differentiation of human leukemia cells in primary culture.
     Leukemia. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
230. HAMMOND CM , Shi Y, White D, Cervi D, et al
     The B-cell calcium sensor predicts progression of chronic lymphocytic leukemia.
     Leukemia. 2008.
     PubMed     Text format     Related articles   
     
     
     
231. DE KEERSMAECKER K , Versele M, Cools J, Superti-Furga G, et al
     Intrinsic differences between the catalytic properties of the oncogenic NUP214-ABL1 and BCR-ABL1 fusion protein kinases.
     Leukemia. 2008;22:2208-16.
     PubMed     Text format     Related articles    Abstract available
     
     
     
232. TAVOR S , Eisenbach M, Jacob-Hirsch J, Golan T, et al
     The CXCR4 antagonist AMD3100 impairs survival of human AML cells and induces their differentiation.
     Leukemia. 2008;22:2151-5158.
     PubMed     Text format     Related articles    Abstract available
     
     
     
233. PELZ-ACKERMANN O , Cross M, Pfeifer H, Deininger M, et al
     Highly sensitive and quantitative detection of BCR-ABL kinase domain mutations by ligation PCR.
     Leukemia. 2008;22:2288-91.
     PubMed     Text format     Related articles   
     
     
     
234. MARTELLI MP , Manes N, Liso A, Pettirossi V, et al
     A western blot assay for detecting mutant nucleophosmin (NPM1) proteins in acute myeloid leukaemia.
     Leukemia. 2008;22:2285-8.
     PubMed     Text format     Related articles   
     
     
     
235. SWORDS R , O'Rafferty C, Giles F, Browne P, et al
     Spurious elevation of the cerebrospinous fluid white cell counts in three patients receiving liposomal cytarabine as part of post-remission therapy.
     Leukemia. 2008;22:2277-8.
     PubMed     Text format     Related articles   
     
     
     
236. SUTTON R , Bahar AY, Kwan E, Giles JE, et al
     Improving minimal residual disease detection in precursor B-ALL based on immunoglobulin-kappa and heavy-chain gene rearrangements.
     Leukemia. 2008;22:2265-7.
     PubMed     Text format     Related articles   
     
     
     
237. ZENZ T , Habe S, Denzel T, Winkler D, et al
     How little is too much? p53 inactivation: from laboratory cutoff to biological basis of chemotherapy resistance.
     Leukemia. 2008;22:2257-8.
     PubMed     Text format     Related articles   
     
     
     November 2008
238. REMSING RIX LL , Rix U, Colinge J, Hantschel O, et al
     Global target profile of the kinase inhibitor bosutinib in primary chronic myeloid leukemia cells.
     Leukemia. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
239. HOLLINK IH , Zwaan CM, Zimmermann M, Arentsen-Peters TC, et al
     Favorable prognostic impact of NPM1 gene mutations in childhood acute myeloid leukemia, with emphasis on cytogenetically normal AML.
     Leukemia. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
240. NEBRAL K , Denk D, Attarbaschi A, Konig M, et al
     Incidence and diversity of PAX5 fusion genes in childhood acute lymphoblastic leukemia.
     Leukemia. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
241. RATEI R , Basso G, Dworzak M, Gaipa G, et al
     Monitoring treatment response of childhood precursor B-cell acute lymphoblastic leukemia in the AIEOP-BFM-ALL 2000 protocol with multiparameter flow cytometry: predictive impact of early blast reduction on the remission status after induction.
     Leukemia. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
242. NIEBUHR B , Iwanski GB, Schwieger M, Roscher S, et al
     Investigation of C/EBPalpha function in human (versus murine) myelopoiesis provides novel insight into the impact of CEBPA mutations in acute myelogenous leukemia (AML).
     Leukemia. 2008.
     PubMed     Text format     Related articles   
     
     
     
243. ROCHA V , Porcher R, Fernandes JF, Filion A, et al
     Association of drug metabolism gene polymorphisms with toxicities, graft-versus-host disease and survival after HLA-identical sibling hematopoietic stem cell transplantation for patients with leukemia.
     Leukemia. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
244. MERLE-BERAL H , Barbier S, Roue G, Bras M, et al
     Caspase-independent type III PCD: a new means to modulate cell death in chronic lymphocytic leukemia.
     Leukemia. 2008.
     PubMed     Text format     Related articles   
     
     
     
245. BURGER JA , Peled A
     CXCR4 antagonists: targeting the microenvironment in leukemia and other cancers.
     Leukemia. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
246. WEGIEL B , Ekberg J, Talasila KM, Jalili S, et al
     The role of VEGF and a functional link between VEGF and p27(Kip1) in acute myeloid leukemia.
     Leukemia. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
247. ALBANO F , Anelli L, Zagaria A, Pannunzio A, et al
     Downregulated expression of genes mapping on chromosome 9 in chronic myeloid leukemia cases bearing genomic deletions on der(9).
     Leukemia. 2008.
     PubMed     Text format     Related articles   
     
     
     
248. DEENIK W , Beverloo HB, van der Poel-van de Luytgaarde SC, Wattel MM, et al
     Rapid complete cytogenetic remission after upfront dasatinib monotherapy in a patient with a NUP214-ABL1-positive T-cell acute lymphoblastic leukemia.
     Leukemia. 2008.
     PubMed     Text format     Related articles   
     
     
     
249. SCHMIEGELOW K , Forestier E, Kristinsson J, Soderhall S, et al
     Thiopurine methyltransferase activity is related to the risk of relapse of childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study.
     Leukemia. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
250. FADERL S , Ferrajoli A, Frankfurt O, Pettitt A, et al
     Treatment of B-cell chronic lymphocytic leukemia with nonchemotherapeutic agents: experience with single-agent and combination therapy.
     Leukemia. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
251. SUNG L , Alibhai SM, Beyene J, Gamis A, et al
     Hematopoietic colony-stimulating factor priming does not influence survival in acute myeloid leukemia: a meta-analysis of randomized trials.
     Leukemia. 2008.
     PubMed     Text format     Related articles   
     
     
     
252. CROSS NC , Daley GQ, Green AR, Hughes TP, et al
     BCR-ABL1-positive CML and BCR-ABL1-negative chronic myeloproliferative disorders: some common and contrasting features.
     Leukemia. 2008;22:1975-89.
     PubMed     Text format     Related articles   
     
     
     
253. XHAARD A , Porcher R, Chien JW, de Latour RP, et al
     Impact of comorbidity indexes on non-relapse mortality.
     Leukemia. 2008;22:2062-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
254. ANDREEFF M , Ruvolo V, Gadgil S, Zeng C, et al
     HOX expression patterns identify a common signature for favorable AML.
     Leukemia. 2008;22:2041-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
255. SIEGEL S , Friedrichs B, Budde AK, Barsoum A, et al
     In-vivo detectable antibodies directed against the oncofetal antigen/immature laminin receptor can recognize and control myeloma cells--clinical implications.
     Leukemia. 2008;22:2115-8.
     PubMed     Text format     Related articles   
     
     
     October 2008
256. RENNEVILLE A , Mialou V, Philippe N, Kagialis-Girard S, et al
     Another pedigree with familial acute myeloid leukemia and germline CEBPA mutation.
     Leukemia. 2008.
     PubMed     Text format     Related articles   
     
     
     
257. SCHOTTE D , Chau JC, Sylvester G, Liu G, et al
     Identification of new microRNA genes and aberrant microRNA profiles in childhood acute lymphoblastic leukemia.
     Leukemia. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
258. ROBERSON JR , Spraker HL, Shelso J, Zhou Y, et al
     Clinical consequences of hyperglycemia during remission induction therapy for pediatric acute lymphoblastic leukemia.
     Leukemia. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
259. GRAUX C , Stevens-Kroef M, Lafage M, Dastugue N, et al
     Heterogeneous patterns of amplification of the NUP214-ABL1 fusion gene in T-cell acute lymphoblastic leukemia.
     Leukemia. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
260. DICKER F , Herholz H, Schnittger S, Nakao A, et al
     The detection of TP53 mutations in chronic lymphocytic leukemia independently predicts rapid disease progression and is highly correlated with a complex aberrant karyotype.
     Leukemia. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
261. GAIPA G , Bugarin C, Longoni D, Cesana S, et al
     Aberrant GM-CSF signal transduction pathway in juvenile myelomonocytic leukemia assayed by flow cytometric intracellular STAT5 phosphorylation measurement.
     Leukemia. 2008.
     PubMed     Text format     Related articles   
     
     
     
262. KASTE SC , Thomas NA, Rai SN, Cheon K, et al
     Asymptomatic kidney stones in long-term survivors of childhood acute lymphoblastic leukemia.
     Leukemia. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
263. KOZAKO T , Yoshimitsu M, Fujiwara H, Masamoto I, et al
     PD-1/PD-L1 expression in human T-cell leukemia virus type 1 carriers and adult T-cell leukemia/lymphoma patients.
     Leukemia. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
264. DVORAKOVA D , Lengerova M, Pospisilova J, Palasek I, et al
     A novel quantitative assessment of minimal residual disease in patients with acute myeloid leukemia carrying NPM1 (nucleophosmin) exon 12 mutations.
     Leukemia. 2008.
     PubMed     Text format     Related articles   
     
     
     
265. TOKI T , Kanezaki R, Adachi S, Fujino H, et al
     The key role of stem cell factor/KIT signaling in the proliferation of blast cells from Down syndrome-related leukemia.
     Leukemia. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
266. BROWN JR , Levine RL, Thompson C, Basile G, et al
     Systematic genomic screen for tyrosine kinase mutations in CLL.
     Leukemia. 2008;22:1966-9.
     PubMed     Text format     Related articles   
     
     
     
267. LUCAS CM , Wang L, Austin GM, Knight K, et al
     A population study of imatinib in chronic myeloid leukaemia demonstrates lower efficacy than in clinical trials.
     Leukemia. 2008;22:1963-6.
     PubMed     Text format     Related articles   
     
     
     
268. KOLLGAARD T , Hadrup SR, Petersen SL, Masmas TN, et al
     Natural T-cell responses against minor histocompatibility antigen (mHag) HY following HLA-matched hematopoietic cell transplantation: what are the requirements for a 'good' mHag?
     Leukemia. 2008;22:1948-51.
     PubMed     Text format     Related articles   
     
     
     
269. PICCOLI C , Ripoli M, Scrima R, Stanziale P, et al
     MtDNA mutation associated with mitochondrial dysfunction in megakaryoblastic leukaemic cells.
     Leukemia. 2008;22:1938-41.
     PubMed     Text format     Related articles   
     
     
     September 2008
270. NGUYEN K , Devidas M, Cheng SC, La M, et al
     Factors influencing survival after relapse from acute lymphoblastic leukemia: a Children's Oncology Group study.
     Leukemia. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
271. HU Y , Chen Y, Douglas L, Li S, et al
     beta-Catenin is essential for survival of leukemic stem cells insensitive to kinase inhibition in mice with BCR-ABL-induced chronic myeloid leukemia.
     Leukemia. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
272. MURATI A , Gervais C, Carbuccia N, Finetti P, et al
     Genome profiling of acute myelomonocytic leukemia: alteration of the MYB locus in MYST3-linked cases.
     Leukemia. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
273. RUSSELL LJ , De Castro DG, Griffiths M, Telford N, et al
     A novel translocation, t(14;19)(q32;p13), involving IGH@ and the cytokine receptor for erythropoietin.
     Leukemia. 2008.
     PubMed     Text format     Related articles   
     
     
     
274. MISAGHIAN N , Ligresti G, Steelman LS, Bertrand FE, et al
     Targeting the leukemic stem cell: the Holy Grail of leukemia therapy.
     Leukemia. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
275. ROHRBACHER M , Berger U, Hochhaus A, Metzgeroth G, et al
     Clinical trials underestimate the age of chronic myeloid leukemia (CML) patients. Incidence and median age of Ph/BCR-ABL-positive CML and other chronic myeloproliferative disorders in a representative area in Germany.
     Leukemia. 2008.
     PubMed     Text format     Related articles   
     
     
     
276. NISHIOKA C , Ikezoe T, Yang J, Koeffler HP, et al
     Blockade of mTOR signaling potentiates the ability of histone deacetylase inhibitor to induce growth arrest and differentiation of acute myelogenous leukemia cells.
     Leukemia. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
277. ZAHER M , Akrout I, Mirshahi M, Kolb JP, et al
     Noxa upregulation is associated with apoptosis of chronic lymphocytic leukemia cells induced by hyperforin but not flavopiridol.
     Leukemia. 2008.
     PubMed     Text format     Related articles   
     
     
     
278. WEINBERG JB , Volkheimer AD, Mihovilovic M, Jiang N, et al
     Apolipoprotein E genotype as a determinant of survival in chronic lymphocytic leukemia.
     Leukemia. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
279. PIGAZZI M , Manara E, Baron E, Basso G, et al
     ICER expression inhibits leukemia phenotype and controls tumor progression.
     Leukemia. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
280. STAAL FJ , Pike-Overzet K, Ng YY, van Dongen JJ, et al
     Sola dosis facit venenum. Leukemia in gene therapy trials: a question of vectors, inserts and dosage?
     Leukemia. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
281. METZLER M , Staege MS, Harder L, Mendelova D, et al
     Inv(11)(q21q23) fuses MLL to the Notch co-activator mastermind-like 2 in secondary T-cell acute lymphoblastic leukemia.
     Leukemia. 2008;22:1812.
     PubMed     Text format     Related articles   
     
     
     
282. MULLER LU , Schore RJ, Zheng Y, Thomas EK, et al
     Rac guanosine triphosphatases represent a potential target in AML.
     Leukemia. 2008;22:1803-6.
     PubMed     Text format     Related articles   
     
     
     
283. KHORASHAD JS , De Melo VA, Fiegler H, Gerrard G, et al
     Multiple sub-microscopic genomic lesions are a universal feature of chronic myeloid leukaemia at diagnosis.
     Leukemia. 2008;22:1806-7.
     PubMed     Text format     Related articles   
     
     
     
284. EL-SHAMI K , Smith BD
     Immunotherapy for myeloid leukemias: current status and future directions.
     Leukemia. 2008;22:1658-64.
     PubMed     Text format     Related articles    Abstract available
     
     
     
285. PARK S , Chapuis N, Bardet V, Tamburini J, et al
     PI-103, a dual inhibitor of Class IA phosphatidylinositide 3-kinase and mTOR, has antileukemic activity in AML.
     Leukemia. 2008;22:1698-706.
     PubMed     Text format     Related articles    Abstract available
     
     
     
286. GARCIA-MANERO G , Stoltz ML, Ward MR, Kantarjian H, et al
     A pilot pharmacokinetic study of oral azacitidine.
     Leukemia. 2008;22:1680-4.
     PubMed     Text format     Related articles    Abstract available
     
     
     
287. SCHYSCHKA L , Rudy A, Jeremias I, Barth N, et al
     Spongistatin 1: a new chemosensitizing marine compound that degrades XIAP.
     Leukemia. 2008;22:1737-45.
     PubMed     Text format     Related articles    Abstract available
     
     
     
288. KOJIMA K , Shimanuki M, Shikami M, Samudio IJ, et al
     The dual PI3 kinase/mTOR inhibitor PI-103 prevents p53 induction by Mdm2 inhibition but enhances p53-mediated mitochondrial apoptosis in p53 wild-type AML.
     Leukemia. 2008;22:1728-36.
     PubMed     Text format     Related articles    Abstract available
     
     
     August 2008
289. CORTES J , Kim DW, Raffoux E, Martinelli G, et al
     Efficacy and safety of dasatinib in imatinib-resistant or -intolerant patients with chronic myeloid leukemia in blast phase.
     Leukemia. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
290. MAO X , Li X, Sprangers R, Wang X, et al
     Clioquinol inhibits the proteasome and displays preclinical activity in leukemia and myeloma.
     Leukemia. 2008.
     PubMed     Text format     Related articles   
     
     
     
291. PAGANIN M , Zecca M, Fabbri G, Polato K, et al
     Minimal residual disease is an important predictive factor of outcome in children with relapsed 'high-risk' acute lymphoblastic leukemia.
     Leukemia. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
292. CASTRO JE , Sandoval-Sus JD, Bole J, Rassenti L, et al
     Rituximab in combination with high-dose methylprednisolone for the treatment of fludarabine refractory high-risk chronic lymphocytic leukemia.
     Leukemia. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
293. TAMAKI H , Yoshihara S, Fujioka T, Kawakami M, et al
     Molecular detection of AML1-MTG8-positive cells in peripheral blood from a patient with isolated extramedullary relapse of t(8;21) acute myeloid leukemia.
     Leukemia. 2008.
     PubMed     Text format     Related articles   
     
     
     
294. SCHMIEGELOW K , Vestergaard T, Nielsen SM, Hjalgrim H, et al
     Etiology of common childhood acute lymphoblastic leukemia: the adrenal hypothesis.
     Leukemia. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
295. CORRADO P , Mancini M, Brusa G, Petta S, et al
     Acetylation of FOXO3a transcription factor in response to imatinib of chronic myeloid leukemia.
     Leukemia. 2008.
     PubMed     Text format     Related articles   
     
     
     
296. KENNEDY JA , Barabe F
     Investigating human leukemogenesis: from cell lines to in vivo models of human leukemia.
     Leukemia. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
297. BUENO C , Montes R, Martin L, Prat I, et al
     NG2 antigen is expressed in CD34+ HPCs and plasmacytoid dendritic cell precursors: is NG2 expression in leukemia dependent on the target cell where leukemogenesis is triggered?
     Leukemia. 2008;22:1475-8.
     PubMed     Text format     Related articles   
     
     
     
298. GERVAIS C , Murati A, Helias C, Struski S, et al
     Acute myeloid leukaemia with 8p11 (MYST3) rearrangement: an integrated cytologic, cytogenetic and molecular study by the groupe francophone de cytogenetique hematologique.
     Leukemia. 2008;22:1567-75.
     PubMed     Text format     Related articles    Abstract available
     
     
     
299. TSCHIEDEL S , Gentilini C, Lange T, Wolfel C, et al
     Identification of NM23-H2 as a tumour-associated antigen in chronic myeloid leukaemia.
     Leukemia. 2008;22:1542-50.
     PubMed     Text format     Related articles    Abstract available
     
     
     
300. MIRANDA MB , Duan R, Thomas SM, Grandis JR, et al
     Gefitinib potentiates myeloid cell differentiation by ATRA.
     Leukemia. 2008;22:1624-7.
     PubMed     Text format     Related articles   
     
     
     
301. STEINBACH D , Debatin KM
     What do we mean by sensitivity when we talk about detecting minimal residual disease?
     Leukemia. 2008;22:1638-9.
     PubMed     Text format     Related articles   
     
     
     
302. SILVA FP , Morolli B, Storlazzi CT, Zagaria A, et al
     ETV6 mutations and loss in AML-M0.
     Leukemia. 2008;22:1639-43.
     PubMed     Text format     Related articles   
     
     
     
303. WINTER PC , McMullin MF, Catherwood MA
     Lack of association of the heparanase gene single-nucleotide polymorphism Arg307Lys with acute lymphoblastic leukaemia in patients from Northern Ireland.
     Leukemia. 2008;22:1629-31.
     PubMed     Text format     Related articles   
     
     
     
304. DAVIDSSON J , Lilljebjorn H, Panagopoulos I, Fioretos T, et al
     BRAF mutations are very rare in B- and T-cell pediatric acute lymphoblastic leukemias.
     Leukemia. 2008;22:1619-21.
     PubMed     Text format     Related articles   
     
     
     
305. MASLAK PG , Dao T, Gomez M, Chanel S, et al
     A pilot vaccination trial of synthetic analog peptides derived from the BCR-ABL breakpoints in CML patients with minimal disease.
     Leukemia. 2008;22:1613-6.
     PubMed     Text format     Related articles   
     
     
     July 2008
306. HIRT A , Schmid AM, Julmy F, Schmitz NM, et al
     Expression of cyclin A in childhood acute lymphoblastic leukemia cells reveals undisturbed G1-S phase transition and passage through the S phase.
     Leukemia. 2008.
     PubMed     Text format     Related articles   
     
     
     
307. GIBBS JD , Liebermann DA, Hoffman B
     Leukemia suppressor function of Egr-1 is dependent on transforming oncogene.
     Leukemia. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
308. LAGADINOU ED , Ziros PG, Tsopra OA, Dimas K, et al
     c-Jun N-terminal kinase activation failure is a new mechanism of anthracycline resistance in acute myeloid leukemia.
     Leukemia. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
309. MACPARTLIN M , Smith AM, Druker BJ, Honigberg LA, et al
     Bruton's tyrosine kinase is not essential for Bcr-Abl-mediated transformation of lymphoid or myeloid cells.
     Leukemia. 2008;22:1354-60.
     PubMed     Text format     Related articles    Abstract available
     
     
     
310. MONY U , Jawad M, Seedhouse C, Russell N, et al
     Resistance to FLT3 inhibition in an in vitro model of primary AML cells with a stem cell phenotype in a defined microenvironment.
     Leukemia. 2008;22:1395-401.
     PubMed     Text format     Related articles    Abstract available
     
     
     
311. ORAZI A , Germing U
     The myelodysplastic/myeloproliferative neoplasms: myeloproliferative diseases with dysplastic features.
     Leukemia. 2008;22:1308-19.
     PubMed     Text format     Related articles    Abstract available
     
     
     
312. WU LX , Xu JH, Zhang KZ, Lin Q, et al
     Disruption of the Bcr-Abl/Hsp90 protein complex: a possible mechanism to inhibit Bcr-Abl-positive human leukemic blasts by novobiocin.
     Leukemia. 2008;22:1402-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
313. GRIESSINGER E , Frelin C, Cuburu N, Imbert V, et al
     Preclinical targeting of NF-kappaB and FLT3 pathways in AML cells.
     Leukemia. 2008;22:1466-9.
     PubMed     Text format     Related articles   
     
     
     
314. JAMAL R , Belisle C, Lessard MC, Hebert J, et al
     Evidence suggesting the presence of a stem cell clone anteceding the acquisition of the JAK2-V617F mutation.
     Leukemia. 2008;22:1472-4.
     PubMed     Text format     Related articles   
     
     
     
315. BEST OG , Gardiner AC, Majid A, Walewska R, et al
     A novel functional assay using etoposide plus nutlin-3a detects and distinguishes between ATM and TP53 mutations in CLL.
     Leukemia. 2008;22:1456-9.
     PubMed     Text format     Related articles   
     
     
     
316. PASQUALUCCI L , Li S, Meloni G, Schnittger S, et al
     NPM1-mutated acute myeloid leukaemia occurring in JAK2-V617F+ primary myelofibrosis: de-novo origin?
     Leukemia. 2008;22:1459-63.
     PubMed     Text format     Related articles   
     
     
     
317. LAWRIE CH , Saunders NJ, Soneji S, Palazzo S, et al
     MicroRNA expression in lymphocyte development and malignancy.
     Leukemia. 2008;22:1440-6.
     PubMed     Text format     Related articles   
     
     
     February 2008
318. HIWARKAR P , Arkenau HT, Treleaven J, Morgan G, et al
     The feasibility of using topotecan, vinorelbine, thiotepa and gemcitabine (TVTG) in adult patients with relapsed/refractory acute lymphoblastic leukaemia/lymphoma.
     Leukemia. 2008;.
     PubMed     Text format     Related articles   
     
     
     January 2008
319. STAMATOPOULOS K , Papadaki T, Pontikoglou C, Athanasiadou I, et al
     Lymphocyte subpopulation imbalances, bone marrow hematopoiesis and histopathology in rituximab-treated lymphoma patients with late-onset neutropenia.
     Leukemia. 2008;.
     PubMed     Text format     Related articles   
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: